Effect of CGS 20267 on ovarian aromatase and gonadotropin levels in the rat

Breast Cancer Research and Treatment

Volumn 48, Issue 1, 1998, Pages 45-51

  Sinha, S ^b   Kaseta, J ^b   Santner, S J ^b   Demers, L M ^b   Bremmer, W J ^b   Santen, R J ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Aromatase inhibitors; Estradiol; Estrogens; Letrozole; Medical ovariectomy; Premenopausal; Uterus

Indexed keywords

AMINOGLUTETHIMIDE; ANDROGEN; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN; FOLLITROPIN; GONADOTROPIN; LETROZOLE; LUTEINIZING HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BREAST CANCER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVE SITE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; OVARY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RAT; UTERUS WEIGHT;

ANIMALS; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; ENZYME INHIBITORS; FEMALE; GONADOTROPINS, PITUITARY; NITRILES; ORGAN SIZE; OVARY; RATS; RATS, SPRAGUE-DAWLEY; TRIAZOLES;

EID: 0031882340     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005937900788     Document Type: Article

References (15)

1. Henderson IC, Canellos GP: Cancer of the breast: the past decade (part I). N Engl J Med 302: 17-30, 1980
2. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR, Bulun SE: Aromatase cytchrome p450, the enzyme responsible for estrogen biosynthesis. Endocrine Rev 15: 342-355, 1994
3. Wells SA Jr, Santen RJ, Lipton A, Haagensen DE Jr, Ruby EJ, Harvey H, Dilley WG: Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma. Ann Surg 187: 475-484, 1978
4. Santen RJ, Manni A, Harvey H, Redmond C: Endocrine treatment of breast cancer in women. Endocrine Rev 11: 221-265, 1990
5. Santen RJ, Samojlik E, Wells SA Jr: Resistance of the ovary to blockade of aromatization with aminoglutethimide. J Clin Endocrinol Metab 51: 473-477, 1980
6. Miller WR: Aromatase inhibitors. Endocrine-related Cancer 3: 65-79, 1996
7. Klein KO, Demers LM, Santner SJ, Baron J, Cutler GB Jr, Santen RJ: Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole. J Clin Endocrinol Metab 80: 2658-2660, 1995
8. Lipton A, Demers LM, Harvey HA, Kambic KB, Grossberg H, Brady C, Adlercreutz H, Trunet PF, Santen RJ: Letrozole (CGS 20267): A phase I study of a new potent oral aromatase inhibitor of breast cancer. Cancer 75: 2134-2138, 1995
9. Petrie EC, Matsumoto AM, Bremmer WJ: Modulation of luteinizing hormone pulse amplitude by the frequency of luteinizing hormone-releasing hormone stimulation and by testosterone in castrated, hypothalamic-lesioned male rats. Biol Reprod 38: 143-149, 1988
10. Banks PK, Meyer K, Brodie AM: Regulation of ovarian steroid biosynthesis by estrogen during proestrus in the rat. Endocrinol 129: 1295-1304, 1991
11. Dowsett M, Jones A, Johnston SRD, Jacobs S, Trunet P, Smith IE: In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer. Clin Cancer Res 1: 1511-1515, 1995
12. Reiter EO, Goldenberg RL, Vaiukaitis JHL, Ross GT: Evidence for a role of estrogen in the ovarian augmentation reaction. Endocrinology 91: 1518-1522, 1973
13. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, Eddy EM, Migliaccio S, Snedeker SM, Lubahn DB, Schomberg DW, Smith EP: Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Progress in Hormone Research 51: 159-186, 1996
14. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K: Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80: 3689-3698, 1995
15. Schieweck K, Bhatnagar AS, Batzl CH, Lang M: Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors. J Steroid Biochem Mol Biol 44: 633-636, 1993